title: [Can antiplatelet therapy be continued in upper gastrointestinal bleeding?].
abstract: During a gastro-intestinal bleeding, treatment options regarding antiplatelet agents depend on the indication. In primary prevention, treatment can reasonably be stopped regarding the low expected benefit. In secondary prevention, experts recommend resuming treatment after a five-day interruption. In patients with a coronary stent, the decision is made on a case by case basis and requires close multidisciplinary collaboration between internists, cardiologists and gastroenterologists.
authors.affiliation: Unité de soins intermédiaires de médecine, Département de médecine interne, réhabilitation et gériatrie, HUG, 1211 Genève 14. sophie.restellini@hcuge.ch
authors.forename: S
authors.initials: S
authors.lastname: Restellini
authors.forename: J-L
authors.initials: JL
authors.lastname: Frossard
authors.forename: M
authors.initials: M
authors.lastname: Louis Simonet
mesh_terms: D000075202:Contraindications; D006471:Gastrointestinal Hemorrhage / Q000150:complications*; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D020521:Stroke / Q000517:prevention & control
chemical_list: D010975:Platelet Aggregation Inhibitors